Singapore markets open in 4 hours 30 minutes

Straits Times Index
3,289.42
-23.93(-0.72%)
S&P 500
5,308.15
+61.47(+1.17%)
Dow
39,908.00
+349.89(+0.88%)
Nasdaq
16,742.39
+231.21(+1.40%)
Bitcoin USD
66,075.31
+4,485.70(+7.28%)
CMC Crypto 200
1,389.55
+121.61(+9.59%)

GILD Jan 2026 67.500 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

8.89

+0.04

(+0.45%)

As of 01:45PM EDT. Market open.

Loading interactive chart…

Business Wire
Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy
SANTA MONICA, Calif., May 14, 2024--Kite, a Gilead Company (Nasdaq: GILD), today announced 12 abstracts from its industry-leading Chimeric Antigen Receptor (CAR) T-cell therapy portfolio at the upcoming 2024 European Hematology Association (EHA) Annual Congress, June 13-16, Madrid, Spain.
Yahoo Finance
One stock is dragging down the S&P 500's earnings growth
S&P 500 companies have had a solid Q1 earnings season, with one key exception: drugmaker Bristol Myers Squibb.
Zacks
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.